CSL Vifor

CSL Vifor
Company typePublic
SIX: VIFN
ISINCH0364749348
IndustryPharmaceutical
Founded1927[1]
Headquarters
Switzerland
Areas served
Worldwide
Key people
Hervé Gisserot (General Manager)[2]
RevenueIncrease CHF 1.75 billion (2021)[3]
Websitewww.viforpharma.com

CSL Vifor is a global specialty pharmaceuticals company in the treatment areas of iron deficiency, dialysis, nephrology & rare disease. It is headquartered in Switzerland and consists of CSL Vifor, Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Sanifit Therapeutics.

  1. ^ "Der reichste Ebener aller Zeiten". Handelszeitung (in German). 2021-12-14. Retrieved 2022-05-10.
  2. ^ Kanstein, Fraiser (2022-08-02). "After delay, CSL's $11.7B deal for Vifor poised to close next week". Fiercepharma. Retrieved 2022-12-29.
  3. ^ Redrup, Yolanda (2022-02-18). "Vifor results show strength as CSL tender period nears end". Australian Financial Review. Retrieved 2022-02-28.